Bsx nyse.

Boston Scientific Closes Acquisition of Relievant Medsystems, Inc. Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept® Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain …Aug 15, 2022 · MARLBOROUGH, Mass., Aug. 15, 2022 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic Material (GEM ™) technology used for embolization of blood vessels in the peripheral vasculature. Embolization is a minimally invasive ... TMFAdriaCimino (< 20) Submitted: 2/20/2020 3:59:14 AM : Start Price: $42.31 NYSE:BSX Score: -3.47 Boston Scientific's many devices as well as a new duodenoscope, used in ERCP procedures will drive revenue. The duodenscope is significant because it is the first FDA-cleared single use one.Dec 4, 2023 · Rock Springs Capital Management LP acquired a new position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 267,500 shares of the medical equipment provider's stock, valued at ...

Nov 29, 2023 · Boston Scientific (NYSE:BSX – Get Free Report) had its price objective upped by research analysts at Canaccord Genuity Group from $60.00 to $64.00 in a research report issued on Monday, Benzinga reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. Canaccord Genuity Group’s price target would suggest a potential upside […]

27 Apr, 2022, 06:30 ET. MARLBOROUGH, Mass., April 27, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.026 billion during the first quarter of 2022, growing ...

19 Mar 2021 ... Operating cash flow had plunged to $310 million from the $1.43 billion that the business generated a year earlier, and free cash flow dropped ...Boston Scientific Corporation (NYSE:BSX) entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. (NasdaqGM:APEN) for approximately $440 million. Nov 30 Boston Scientific Corporation Announces the First Results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) Study27 Jul 2023 ... PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.599 billion during the second quarter of 2023, ...Boston Scientific (NYSE: BSX) is a stock that at first glance should be on a list of stocks to buy not stocks to sell.The company operates in the medical devices sector. The sector went nowhere ...

On the Bermuda Stock Exchange, shares in the two publicly traded domestic insurers changed hands ... For the week, the RG/BSX Index was up 243.25 points, or 11.34 per cent, on share volume of ...

MARLBOROUGH, Mass., Feb. 2, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.127 billion during the fourth quarter of 2021, growing 15.4 percent on a reported basis, 16.9 percent on an operational 1 basis and 15.1 percent on an organic 2 basis, all compared to the prior year period. The company …

5. Boston Scientific Corporation (NYSE: BSX) Number of Hedge Fund Holders In Q2 2023: 69. Market Capitalization: $73.9 Billion. Founded in 1979 and headquartered in Massachusetts, Boston ...On October 18, 2023, Boston Scientific Corporation (NYSE:BSX) stock closed at $50.71 per share. One-month return of Boston Scientific Corporation (NYSE:BSX) was -5.82%, and its shares gained 26.35 ...BSX 30-Year Financial Data. The intrinsic value of BSX. Boston Scientific is a leading producer of less invasive medical devices that are inserted into the human body through small openings or cuts.On October 18, 2023, Boston Scientific Corporation (NYSE:BSX) stock closed at $50.71 per share. One-month return of Boston Scientific Corporation (NYSE:BSX) was -5.82%, and its shares gained 26.35 ...Veja a previsão de preço das ações da Boston Scientific Corporation para 1 ano, feita pelos analistas e compare-a com as mudanças de preço ao longo do tempo para desenvolver uma melhor estratégia de negociação.Tax Effect of Unusual Items. -68,632. -149,867. -20,944. -221,670. -60,210. Get the detailed quarterly/annual income statement for Boston Scientific Corporation (BSX). Find out the revenue ...

In certain circumstances, securities with respect to which the relevant exchange has commenced delisting proceedings may continue to be traded pending appeal of that …Boston Scientific (BSX) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.73.38%. Get the latest Boston Scientific Corporation (BSX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...Feb 3, 2023 · MARLBOROUGH, Mass., Feb. 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LithoVue™ Elite Single ... Boston Scientific has a total shareholder equity of $19.1B and total debt of $8.9B, which brings its debt-to-equity ratio to 46.5%. Its total assets and total liabilities are $34.0B and $14.9B respectively. Boston Scientific's EBIT is $2.3B making its interest coverage ratio 9.2. It has cash and short-term investments of $952.0M.

Find the latest Boston Scientific Corporation (BSX) stock quote, history, news and other vital information to help you with your stock trading and investing.

On July 24, 2023, Boston Scientific Corporation (NYSE:BSX) stock closed at $52.17 per share. One-month return of Boston Scientific Corporation (NYSE:BSX) was -2.49%, and its shares gained 37.29% ...Boston Scientific Corporation (NYSE:BSX) entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. (NasdaqGM:APEN) for approximately $440 million. Nov 30 Boston Scientific Corporation Announces the First Results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) StudyFind the latest Boston Scientific Corporation (BSX) stock quote, history, news and other vital information to help you with your stock trading and investing.Boston Scientific Co. (NYSE:BSX – Get Free Report) has received a consensus rating of “Buy” from the sixteen analysts that are covering the company, Marketbeat Ratings reports.One research analyst has rated the stock with a hold recommendation, fourteen have given a buy recommendation and one has issued a …WebBoston Scientific Corp stock price (BSX) NYSE: BSX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Boston Scientific Corp stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.MARLBOROUGH, Mass., Oct. 6, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments.The acquisition will expand the Boston Scientific electrophysiology …

Dec 4, 2023 · Boston Scientific last released its quarterly earnings results on October 26th, 2023. The medical equipment provider reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. The company earned $3.53 billion during the quarter, compared to the consensus estimate of $3.48 billion.

Earnings for Boston Scientific are expected to grow by 10.95% in the coming year, from $2.01 to $2.23 per share. Boston Scientific has not formally confirmed its next …

The latest price target for . Boston Scientific (NYSE: BSX) was reported by Canaccord Genuity on Monday, November 27, 2023.The analyst firm set a price target for 64.00 expecting BSX to rise to ...Dec 1, 2023 · See the latest Boston Scientific Corp stock price (BSX:XNYS), related news, valuation, dividends and more to help you make your investing decisions. May 20, 2023 · MARLBOROUGH, Mass., May 20, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company's key electrophysiology and cardiac rhythm management ... /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a... BSX: 51.56 (+0.25%) Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device PR Newswire - Wed Sep 6, 3:00PM CDTWebMARLBOROUGH, Mass., Sept. 1, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced the close of its acquisition of the global surgical business of Lumenis LTD., a privately-held ...Nov 6, 2023 · Boston Scientific Corp. (NYSE:BSX) trade information. Instantly BSX has been showing a green trend so far today with a performance of 0.09% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 53.10 on Friday, 11/03/23 increased the stock’s daily price by 0.98%. Boston Scientific's estimated fair value is US$41.64 based on 2 Stage Free Cash Flow to Equity. Boston Scientific's US$51.11 share price signals that it might be 23% overvalued. The US$53.11 ...WebRecently. Price. BSX. 53.91. Webull offers kinds of Boston Scientific Corporation stock information, including NYSE:BSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BSX stock news, and many more online research tools to help you make informed decisions.Company to add novel technology cleared for use in peripheral vasculature to interventional oncology and embolization portfolio. MARLBOROUGH, Mass., Aug. 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic …MARLBOROUGH, Mass., Sept. 1, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced the close of its acquisition of the global surgical business of Lumenis LTD., a privately-held ...Tax Effect of Unusual Items. -68,632. -149,867. -20,944. -221,670. -60,210. Get the detailed quarterly/annual income statement for Boston Scientific Corporation (BSX). Find out the revenue ...

BSX Stock 12 Months Forecast. $60.95. (9.94% Upside) Based on 21 Wall Street analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is $60.95 with a high forecast of $67.00 and a low forecast of $58.00. The average price target represents a 9.94% change from the last price of $55.44. 9 Nov 2023 ... Boston Scientific (NYSE: BSX) reported its Q3 results last month, with revenues and earnings beating the street estimates.21 Apr, 2020, 08:00 ET. MARLBOROUGH, Mass., April 21, 2020 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has signed a virtual power purchase agreement (VPPA) that represents the ...The RG/BSX Index closed on Monday at 2,171.20, up 53.63 points (2.53 per cent). Some 3,500 shares in Bank of NT Butterfield Ltd changed hands on the Bermuda Stock Exchange.Instagram:https://instagram. aa stocksgreat stocks to shortsandp 500 betayieldmax etfs Nov 28, 2023 · Boston Scientific Corporation (NYSE:BSX), known for its innovative stent technology in heart surgery, has recently ventured into chronic pain management.The company’s strategic acquisition of ... molina insurance reviewsis fisher investment any good Boston Scientific's stock is currently priced at $54.33 per share, giving it a market cap of $79.60 billion. The company's GF Value, an estimation of its fair value, is $50.49, suggesting that the ... dow jones sandp nasdaq The latest Boston Scientific stock prices, stock quotes, news, and BSX history to help you invest and trade smarter. ... After-market 07:27:17 PM EDT 12/1/2023 NYSE. Start Trading.RE. UBS Raises Boston Scientific Price Target to $67 From $66, Maintains Buy Rating. 10-27. MT. Oppenheimer Adjusts Boston Scientific Price Target to $58 From $59, Maintains Perform Rating. 10-27. MT. Needham Adjusts Price Target on Boston Scientific to $60 From $65, Maintains Buy Rating. 10-27.Oct 5, 2023 · 14. Boston Scientific Corporation (NYSE: BSX) Value of Point72 Asset Management’s 13F Position: $188.8 million. Number of Hedge Fund Shareholders: 71. Boston Scientific Corporation (NYSE:BSX) is ...